Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice. 2002

Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
University of Alabama, Birmingham, AL 35294, USA. Huang-Ge.Zhang@cc.uab.edu

Collagen II (CII)-induced arthritis in DBA/1j mice is mediated by both CII-reactive T cells and anti-CII Ab-producing B cells. To determine the relative role of these processes in the development of arthritis, we specifically eliminated CII-reactive T cells by treating the mice with CII-pulsed syngeneic macrophages that had been transfected with a binary adenovirus system. These macrophages express murine Fas ligand in a doxycycline-inducible manner with autocrine suicide inhibited by concomitant expression of p35. The mice were treated i.v. with four doses of CII-APC-AdFasLp35Tet or a single dose of AdCMVsTACI (5 x 10(9) PFU), or both simultaneously, beginning 2 wk after priming with CII in CFA. Treatment with CII-APC-AdFasLp35Tet alone or in combination with a single dose of AdCMVsTACI prevented the development of CII-induced arthritis and T cell infiltration in the joint. The elimination of T cells was specific in that a normal T cell response was observed on stimulation with OVA after treatment with CII-APC-AdFasLp35Tet. Treatment with AdCMVsTACI alone prevented production of detectable levels of circulating anti-CII autoantibodies and reduced the severity of arthritis but did not prevent its development. These results indicate that the CII-reactive T cells play a crucial role in the development of CII-induced arthritis and that the anti-CII Abs act to enhance the development of CII-induced arthritis.

UI MeSH Term Description Entries
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D002358 Cartilage, Articular A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact. Articular Cartilage,Articular Cartilages,Cartilages, Articular
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
August 2002, Journal of immunology (Baltimore, Md. : 1950),
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
October 1997, Experimental animals,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
January 2007, Journal of applied toxicology : JAT,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
January 2007, Journal of applied toxicology : JAT,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
September 1999, Biochimica et biophysica acta,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
January 2005, Clinical and experimental rheumatology,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
March 1999, Proceedings of the National Academy of Sciences of the United States of America,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
November 2012, Experimental & molecular medicine,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
January 2015, Mediators of inflammation,
Huang-Ge Zhang, and PingAr Yang, and Jinfu Xie, and Zhongyu Liu, and Di Liu, and Liang Xiu, and Tong Zhou, and Yongming Wang, and Hui-Chen Hsu, and John D Mountz
January 2004, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!